We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+16.98%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$295B
AUM Growth
+$35.4B
(+14%)
Cap. Flow
-$1.58B
Cap. Flow
% of AUM
-0.53%
Top 10 Holdings %
Top 10 Hldgs %
22.42%
Holding
3,425
New
145
Increased
1,798
Reduced
1,253
Closed
125
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1B |
| 2 |
Apple
AAPL
|
+$797M |
| 3 |
Merck
MRK
|
+$316M |
| 4 |
Amazon
AMZN
|
+$308M |
| 5 |
Medtronic
MDT
|
+$298M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$587M |
| 2 |
NXP Semiconductors
NXPI
|
+$554M |
| 3 |
Meta Platforms (Facebook)
META
|
+$449M |
| 4 |
Intuit
INTU
|
+$433M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.73% |
| 2 | Healthcare | 13.29% |
| 3 | Consumer Discretionary | 13.23% |
| 4 | Financials | 12.2% |
| 5 | Communication Services | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXLA
3076
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $375K | ﹤0.01% |
2,889
+13
| +0.5% | +$1.67K |
|
3077
First Bank
FRBA
$454M
| $374K | ﹤0.01% |
39,869
+482
| +1% | +$4.13K |
|
|
PSTX
3078
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $370K | ﹤0.01% |
33,702
+11,274
| +50% | +$119K |
|
3079
Establishment Labs
ESTA
$2.28B
| $369K | ﹤0.01% |
9,810
-149,478
| -94% | -$3.94M |
|
3080
Concrete Pumping Holdings
BBCP
$491M
| $368K | ﹤0.01% |
96,030
+27,408
| +40% | +$99.6K |
|
3081
Harmony Biosciences
HRMY
$2.24B
| $367K | ﹤0.01% |
+10,157
| New | +$410K |
|
|
FARM
3082
DELISTED
Farmer Brothers
FARM
| $362K | ﹤0.01% |
77,558
+3,632
| +5% | +$15.6K |
|
3083
Evolution Petroleum
EPM
$131M
| $360K | ﹤0.01% |
126,254
-468
| -0.4% | -$1.19K |
|
|
PFHD
3084
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
| $360K | ﹤0.01% |
23,352
+1,059
| +5% | +$15.4K |
|
|
SOHU
3085
Sohu.com
SOHU
$357M
| $356K | ﹤0.01% |
22,341
-8,000
| -26% | -$147K |
|
|
FONR
3086
DELISTED
Fonar
FONR
| $351K | ﹤0.01% |
20,236
+10,147
| +101% | +$198K |
|
|
ONCR
3087
DELISTED
Oncorus, Inc.
ONCR
| $351K | ﹤0.01% |
+10,863
| New | +$252K |
|
3088
Envela
ELA
$446M
| $350K | ﹤0.01% |
67,218
| – | – |
|
3089
First United
FUNC
$289M
| $345K | ﹤0.01% |
22,256
+11,470
| +106% | +$165K |
|
|
SLNO
3090
DELISTED
Soleno Therapeutics
SLNO
| $341K | ﹤0.01% |
11,773
+3,300
| +39% | +$95.2K |
|
3091
LENSAR
LNSR
$74.2M
| $340K | ﹤0.01% |
+46,937
| New | +$403K |
|
|
ALSK
3092
DELISTED
Alaska Communications Systems
ALSK
| $333K | ﹤0.01% |
174,246
+3,075
| +2% | +$8.77K |
|
|
PHAS
3093
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $332K | ﹤0.01% |
98,856
+154
| +0.2% | +$551 |
|
|
SLCT
3094
DELISTED
Select Bancorp, Inc.
SLCT
| $332K | ﹤0.01% |
35,064
+781
| +2% | +$6.79K |
|
3095
Safe Bulkers
SB
$774M
| $330K | ﹤0.01% |
254,383
+7,866
| +3% | +$8.45K |
|
|
SCTL
3096
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $320K | ﹤0.01% |
112,536
+3,062
| +3% | +$6.89K |
|
3097
Eton Pharmaceutcials
ETON
$1.22B
| $318K | ﹤0.01% |
39,155
+986
| +3% | +$7.61K |
|
3098
Mid Penn Bancorp
MPB
$952M
| $313K | ﹤0.01% |
14,300
| – | – |
|
3099
Revolve Group
RVLV
$1.73B
| $312K | ﹤0.01% |
+10,004
| New | +$223K |
|
3100
CalciMedica
CALC
$10.9M
| $311K | ﹤0.01% |
+766
| New | +$226K |
|
Similar funds
VFT
Nuveen's Q4 2020 Portfolio in Review
As of Q4 2020, Nuveen held 3,425 positions worth $295B, up 14% from $260B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Nuveen's Q4 2020 filing shows 145 new, 1,798 increased, 1,253 reduced and 125 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M. The largest sale was Walt Disney, an estimated $587M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Nuveen's largest Q4 2020 buy was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M.
- Nuveen added most to Microsoft in Q4 2020, an estimated $1B increase.
- Nuveen's biggest Q4 2020 reduction was Walt Disney, cutting an estimated $587M.
- Nuveen fully exited Alcon in Q4 2020, selling an estimated $174M.
- Nuveen's ten largest holdings make up 22% of its $295B portfolio in Q4 2020.
- Nuveen opened 145 new positions and closed 125 in Q4 2020.
- Nuveen's portfolio value rose 14% quarter-over-quarter to $295B.
Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.